{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T22:07:13Z","timestamp":1790287633701,"version":"4.1.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2001,5,1]],"date-time":"2001-05-01T00:00:00Z","timestamp":988675200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Obes"],"published-print":{"date-parts":[[2001,5]]},"DOI":"10.1038\/sj.ijo.0801592","type":"journal-article","created":{"date-parts":[[2002,9,19]],"date-time":"2002-09-19T16:34:38Z","timestamp":1032453278000},"page":"741-747","source":"Crossref","is-referenced-by-count":28,"title":["Second phase of a double-blind study clinical trial on Sibutramine for the treatment of patients suffering essential obesity: 6 months after treatment cross-over"],"prefix":"10.1038","volume":"25","author":[{"given":"G","family":"Fangh\u00e4nel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Cortinas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"S\u00e1nchez-Reyes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Berber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2001,5,7]]},"reference":[{"key":"BF0801592_CR1","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/S0149-2918(96)80057-9","volume":"18","author":"XA Pi-Sunyer","year":"1996","unstructured":"Pi-Sunyer XA . A review of long-term studies evalutating the efficacy of weight loss in ameliorating disorders associated with obesity Clin Ther 1996 18: 1006\u20131036.","journal-title":"Clin Ther"},{"key":"BF0801592_CR2","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1093\/ajcn\/68.4.899","volume":"68","author":"listed No author","year":"1998","unstructured":"No author listed . Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: Executive summary Am J Clin Nutr 1998 68: 899\u2013917.","journal-title":"Am J Clin Nutr"},{"key":"BF0801592_CR3","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1002\/j.1550-8528.1995.tb00194.x","volume":"3","author":"JS Stern","year":"1995","unstructured":"Stern JS, Hirsch J, Blair SN, Foreyt JP, Frank A, Kumanyika SK, Madans JH, Marlatt GA, St Jeor ST and Stunkard AJ . Weighing the options: criteria for evaluating weight-management programs. The Committee to Develop Criteria for Evaluating the Outcomes of Approaches to Prevent and Treat Obesity Obes Res 1995 3: 591\u2013604.","journal-title":"Obes Res"},{"key":"BF0801592_CR4","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1002\/j.1550-8528.1995.tb00144.x","volume":"3","author":"JD DePue","year":"1005","unstructured":"DePue JD, Clark MM, Ruggiero L, Mediros ML and Pera V Jr . Maintenance of weight loss: a needs assessment Obes Res 1005 3: 241\u20138.","journal-title":"Obes Res"},{"key":"BF0801592_CR5","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1001\/jama.1996.03540230057036","volume":"276","author":"Prevention National Task Force on the","year":"1996","unstructured":"National Task Force on the Prevention and Treatment of Obesity . Long-term Pharmacotherapy in the management of obesity JAMA 1996 276: 1907\u20131915.","journal-title":"JAMA"},{"issue":"Suppl 1","key":"BF0801592_CR6","first-page":"S25","volume":"21","author":"MJ Stock","year":"1997","unstructured":"Stock MJ . Sibutramine: a review of the pharmacology of a novel anti-obesity agent Int J Obes Relat Metab Disord 1997 21 (Suppl 1): S25\u2013S29.","journal-title":"Int J Obes Relat Metab Disord"},{"key":"BF0801592_CR7","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1097\/00004714-199806000-00008","volume":"18","author":"JO Cole","year":"1998","unstructured":"Cole JO, Levin A, Beake B, Kaiser PE and Schienbaum ML . Sibutramine: A new weight loss agent without evidence of the abuse potential associated with amphetamines J Clin Psycopharmacol 1998 18: 231\u2013236.","journal-title":"J Clin Psycopharmacol"},{"key":"BF0801592_CR8","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s002130050001","volume":"147","author":"LM Schuh","year":"2000","unstructured":"Schuh LM, Schuster CR, Hooper JA, Mendel CM . Abuse liability assessment of Sibutramine, a novel weight control agent Psycopharmacology (Berl). 2000 147: 339\u2013346.","journal-title":"Psycopharmacology (Berl)."},{"key":"BF0801592_CR9","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1093\/ajcn\/68.6.1180","volume":"68","author":"DL Hansen","year":"1998","unstructured":"Hansen DL, Toubro S, Stock MJ, Macdonald IA and Astrup A . Thermogenic effects of Sibutramine in humans Am J Clin Nutr 1998 68: 1180\u20131186.","journal-title":"Am J Clin Nutr"},{"key":"BF0801592_CR10","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/clpt.1991.144","volume":"50","author":"M Weintraub","year":"1991","unstructured":"Weintraub M, Rubio A, Golik A, Byrne L and Scheinbaum ML . Sibutramine in weight control: A dose-ranging, efficacy study Clin Pharmacol Ther 1991 50: 33\u2013337.","journal-title":"Clin Pharmacol Ther"},{"key":"BF0801592_CR11","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1002\/j.1550-8528.1996.tb00544.x","volume":"4","author":"GA Bray","year":"1996","unstructured":"Bray GA, Ryan DH, Gordon D, Heidingfelder S, Cerise F and Wilson K . A double-blind randomized placebo-controlled trial of Sibutramine Obes Res 1996 4: 263\u2013270.","journal-title":"Obes Res"},{"key":"BF0801592_CR12","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1002\/j.1550-8528.1999.tb00701.x","volume":"7","author":"GA Bray","year":"1999","unstructured":"Bray GA, Blackburn GL, Ferguson JM, Greenway FL, Jain AK, Mendel CM, Mendels J, Ryan DH, Schwartz SL, Scheinbaum ML, Seaton TB . Sibutramine produces dose-related weight loss Obes Res 1999 7: 189\u2013198.","journal-title":"Obes Res"},{"key":"BF0801592_CR13","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/sj.ijo.0800540","volume":"22","author":"C Hanotin","year":"1998","unstructured":"Hanotin C, Thomas F, Jones SP, Leutenegger E and Drouin P . Efficacy and tolerability of Sibutramine in obese patients: a dose- ranging study Int J Obes Relat Metab Disord 1998 22 32\u201338.","journal-title":"Int J Obes Relat Metab Disord"},{"key":"BF0801592_CR14","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/oby.2000.10","volume":"8","author":"GE Mat\u00ednez-Cuellar","year":"2000","unstructured":"Mat\u00ednez-Cuellar GE, Mart\u00ednez-Ruiz A, Revilla-Monsalve MC, Berber A . Six-month treatment of obesity with Sibutramine 15\u2005mg; a double-blind, placebo-controlled monocenter clinical trial in a Hispanic population Obes Res 2000 8: 71\u201382.","journal-title":"Obes Res"},{"key":"BF0801592_CR15","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1093\/ajcn\/60.5.647","volume":"60","author":"DJ Goldstein","year":"1994","unstructured":"Goldstein DJ, Potvin JH . Long-term weight loss: the effect of pharmacologic agents Am J Clin Nutr 1994 60: 647\u2013657.","journal-title":"Am J Clin Nutr"},{"key":"BF0801592_CR16","first-page":"129","volume":"18","author":"DJ Goldstein","year":"1994","unstructured":"Goldstein DJ, Rampey AH Jr, Enas GG, Potvin JH, Fludzinski LA, Levine LR . Fluoxetine: a randomized clinical trial in the treatment of obesity Int J Obes Relat Metab Disord 1994 18: 129\u2013135.","journal-title":"Int J Obes Relat Metab Disord"},{"key":"BF0801592_CR17","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1002\/j.1550-8528.1995.tb00178.x","volume":"3","author":"listed No authors","year":"1995","unstructured":"No authors listed . Guidelines for the approval and use of drugs to treat obesity. A position paper of the North American Association for the Study of Obesity Obes Res 1995 3: 473\u2013478.","journal-title":"Obes Res"},{"key":"BF0801592_CR18","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/S0002-9343(98)00411-2","volume":"106","author":"M Apfelbaum","year":"1999","unstructured":"Apfelbaum M, Vague P, Ziegler O, Hanotin C, Thomas F, Leutenegger E . Long-term maintenance of weight loss after a very-low-caloric diet: A randomized blinded trial of the efficacy and tolerability of Sibutramine A J Med 1999 106: 179\u2013184.","journal-title":"A J Med"},{"key":"BF0801592_CR19","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1007\/BF00238557","volume":"71","author":"DL Ballor","year":"1995","unstructured":"Ballor DL, Poehlman ET . A meta-analysis of the effects of exercise and\/or dietary restriction on resting metabolic rate Eur J Appl Physiol 1995 71 535\u2013542.","journal-title":"Eur J Appl Physiol"},{"key":"BF0801592_CR20","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1123\/ijsn.6.1.41","volume":"6","author":"JL Thompson","year":"1996","unstructured":"Thompson JL, Manore MM, Thomas JR . Effects of diet and diet-plus-exercise programs on resting metabolic rate: a meta-analysis Int J Sport Nutr 1996 6 41\u201361.","journal-title":"Int J Sport Nutr"},{"key":"BF0801592_CR21","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1038\/sj.ijo.0801045","volume":"23","author":"KM Walsh","year":"1999","unstructured":"Walsh KM, Leen E, Lean ME . The effects of Sibutramine on resting energy expenditure and adrenaline-induced thermogenesis in obese females Int J Obes Relat Metab Disord 1999 23: 1009\u20131015.","journal-title":"Int J Obes Relat Metab Disord"},{"key":"BF0801592_CR22","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1038\/sj.ijo.0801059","volume":"23","author":"DL Hansen","year":"1999","unstructured":"Hansen DL, Toubro S, Stock MJ, MacDonald IA, Astrup A . The effect of Sibutramine on energy expenditure and appetite during chronic treatment without dietary restriction Int J Obes Relat Metab Disord 1999 23: 1016\u20131024.","journal-title":"Int J Obes Relat Metab Disord"}],"container-title":["International Journal of Obesity"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/0801592.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/0801592","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/0801592.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,16]],"date-time":"2023-05-16T07:17:22Z","timestamp":1684221442000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/0801592"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,5]]},"references-count":22,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2001,5]]}},"alternative-id":["BF0801592"],"URL":"https:\/\/doi.org\/10.1038\/sj.ijo.0801592","relation":{},"ISSN":["0307-0565","1476-5497"],"issn-type":[{"value":"0307-0565","type":"print"},{"value":"1476-5497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,5]]}}}